WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

CLINICAL EUALUTION OF THE EFFICACY ON TARPAN KARMA IN DRY EYE SYNDROME W.S.R. TO BLEPHARITIS (KRIMIGRANTHI) BY JIVANTIYADI GHRITTA USING FIUROSCEIN AND ROSE BENGAL CORNEAL STAINING

Dr. Jitendra Kumar*, Dr. Purnima Rao and Dr. B. Mukhopadhya

ABSTRACT

Dry eye syndrome is a very common condition that is characterized by a disturbance of the tear film. Affecting a significant percentage of the population especially aged 40 or above is the persons most likely to be affected by dry eyes.[1] Dry eye syndrome affects any race and more common in women Tears are a combination of water, for moisture; oils, for lubrication; mucus, for even spreading; and antibodies and special proteins, for resistance to infection. These components are secreted by special glands located around the eye. Krimigranthi is a Sandhigata Roga (Pakshama-Vartma Sandhigata). It is Kaphaja Sadhya Vyadhi described in Sushruta Samhita.[2] It is characterised by irritation, small nodules, and inflammation of eye lids. It is correlated with Blepharitis with modern ophthalmology. Blepharitis is an eye condition characterized by chronic inflammation of the eyelid, the severity and time course of which can vary.[3] Onset can be acute, resolving without treatment within 2–4 weeks (this can be greatly reduced with lid hygiene), but more generally is a long standing inflammation varying in severity. It may be classified as Seborrhoeic, Staphylococcal, Mixed, Posterior or Meibomitis, or Parasitic.[4] On the other way Tarpana means also Santarpana, by mean of which the body tissue grow, find strength and become strong. Here, in this study main concern was with second variety of Tarpana by means of which the eye shed their weakness and attains better sight. We have tried to observe the role of Tarpan Karma in dry eye syndrome in present clinical study in Blepharitis. The Tarpan Karma with Jivantiyadi Ghritta has been selected as trail drugs and conventional treatment i.e. Artificial tears was selected as a control drug in this present research work for evaluating their roles in the management of a series of patients of dry eyes who were selected on the basis of specialised Performa prepared for this purpose.

Keywords: Dry eye syndrome, Blepharitis (Krimigranthi), Jivantiyadi Ghritta, Tarpan Karma Fluorescin and Rose Bengal Staining.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More